Skip to content

To evaluate the efficacy and safety of unani drug in ihtibas e tams(Ammenorrhoea)

clinical validation of unani pharmacopeial formulation -Jawarish Qurtum in Ihtibas e Tams(Ammenorrhoea)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/11/047144
Enrollment
75
Registered
2022-11-09
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N911- Secondary amenorrhea

Interventions

Intervention1: jawarish qurtum: : Jawarish-e-Qurtum Semi solidform The drug is used orally 5g BD With water for 3 months Control Intervention1: nil: nil

Sponsors

central council for research in unani medicine
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Women of age group 18-45 years complaining of absence of menstruation for last 3 or more months

Exclusion criteria

Exclusion criteria: 1.Pregnancy 2.Lactation 3.Menopause 4.Primary amenorrhoea 5.Tumours 6.Patients with gross structural abnormalities of uterus, thyroid disease 7.Congenital abnormalities 8.Patients with abnormal prolactin, abnormal thyroid function tests. 9 clinically significant diseases that might have limited participation in or completion of the study including any anatomical abnormality or gynaecological neoplasia severe drug allergy 10.Intake of any hormonal products (chemical or herbal) in the previous 2 months.

Design outcomes

Primary

MeasureTime frame
ocurence ofbleeding / periodsTimepoint: ocurence ofbleeding / periods in first treatment cycle at 30th day,60th day and 120th day

Secondary

MeasureTime frame
regulation of bleeding patternTimepoint: regulation of bleeding pattern in three cycles;regulation of normal bleeding pattern /occurence of bleedingTimepoint: regulation of normal bleeding pattern at 30th day,60 th day and at 120th day

Countries

India

Contacts

Public ContactDr HUMMA

Regional research institute of unani medicine Srinagar/CCRUM

humaccrum@gmail.com9796550059

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026